Aliases & Classifications for Suppression Amblyopia

MalaCards integrated aliases for Suppression Amblyopia:

Name: Suppression Amblyopia 12 15
Amblyopia 44 72
Amblyopia, Suppression 72
Strabismic Amblyopia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10375
ICD9CM 35 368.01
MeSH 44 D000550
SNOMED-CT 68 35600002
ICD10 33 H53.03
UMLS 72 C0002418 C0750903

Summaries for Suppression Amblyopia

MalaCards based summary : Suppression Amblyopia, also known as amblyopia, is related to amblyopia and disuse amblyopia, and has symptoms including photophobia, other specified visual disturbances and visual disturbance. An important gene associated with Suppression Amblyopia is SIRPA (Signal Regulatory Protein Alpha). The drugs Tropicamide and Atropine have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and cortex, and related phenotype is Increased shRNA abundance.

Related Diseases for Suppression Amblyopia

Diseases related to Suppression Amblyopia via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 263, show less)
# Related Disease Score Top Affiliating Genes
1 amblyopia 30.0 SIRPA DPT
2 disuse amblyopia 12.5
3 mental and growth retardation with amblyopia 12.2
4 microphthalmia, isolated 6 11.6
5 farsightedness 11.6
6 astigmatism 11.6
7 duane retraction syndrome 1 11.6
8 peters-plus syndrome 11.4
9 hemifacial hyperplasia with strabismus 11.4
10 isolated ectopia lentis 11.4
11 paralytic squint 11.4
12 blepharophimosis, ptosis, and epicanthus inversus 11.2
13 duane retraction syndrome 2 11.2
14 corneal dystrophy, congenital stromal 11.2
15 bestrophinopathy, autosomal recessive 11.2
16 cerulean cataract 11.2
17 aniridia 1 11.1
18 aniridia and absent patella 11.1
19 cataract 41 11.1
20 fibrosis of extraocular muscles, congenital, 1 11.1
21 bornholm eye disease 11.1
22 fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement 11.1
23 mental retardation, anterior maxillary protrusion, and strabismus 11.1
24 cognitive impairment with or without cerebellar ataxia 11.1
25 duane retraction syndrome 3 with or without deafness 11.1
26 aniridia 2 11.1
27 duane syndrome type 2 11.1
28 hivep2-related intellectual disability 11.1
29 isolated duane retraction syndrome 11.1
30 monocular esotropia 10.8
31 esotropia 10.8
32 anisometropia 10.7
33 ptosis 10.6
34 refractive error 10.6
35 eye disease 10.6
36 pathologic nystagmus 10.5
37 ocular dominance 10.5
38 congenital ptosis 10.5
39 hemangioma 10.4
40 microvascular complications of diabetes 5 10.4
41 alternating exotropia 10.4
42 exotropia 10.4
43 scotoma 10.4
44 47,xyy 10.4
45 lacrimal duct defect 10.3
46 optic nerve disease 10.3
47 intraocular pressure quantitative trait locus 10.2
48 achromatopsia 10.2
49 3-methylglutaconic aciduria, type iii 10.2
50 macular degeneration, age-related, 1 10.2
51 familial cold autoinflammatory syndrome 3 10.2
52 aniseikonia 10.2
53 cycloplegia 10.2
54 ametropic amblyopia 10.2
55 myopia 10.2
56 acute retrobulbar neuritis 10.2
57 neuritis 10.2
58 retinal vascular disease 10.2
59 conjunctivitis 10.2
60 cataract 10.2
61 cyclotropia 10.2
62 accommodative esotropia 10.2
63 posttransplant acute limbic encephalitis 10.2
64 ocular motor apraxia 10.2
65 neuropathy 10.2
66 retinal detachment 10.1
67 asthenopia 10.1
68 optic neuritis 10.1
69 uveitis 10.1
70 dyslexia 10.1
71 alcohol dependence 10.1
72 keratoconus 10.1
73 brown's tendon sheath syndrome 10.1
74 blepharophimosis 10.1
75 ocular motility disease 10.1
76 capillary hemangioma 10.1
77 strabismus 10.0
78 mechanical strabismus 10.0
79 exudative vitreoretinopathy 1 10.0
80 keratitis, hereditary 10.0
81 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
82 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
83 vitamin b12 deficiency 10.0
84 nutritional optic neuropathy 10.0
85 abnormal retinal correspondence 10.0
86 alcohol use disorder 10.0
87 keratopathy 10.0
88 crohn's disease 10.0
89 albinism 10.0
90 48,xyyy 10.0
91 color vision deficiency 10.0
92 cerebral visual impairment 10.0
93 hereditary optic neuropathy 10.0
94 cleft palate, isolated 9.9
95 corneal dystrophy, posterior polymorphous, 1 9.9
96 neurofibromatosis, type iv, of riccardi 9.9
97 optic nerve hypoplasia, bilateral 9.9
98 polykaryocytosis inducer 9.9
99 retinoblastoma 9.9
100 torticollis 9.9
101 charge syndrome 9.9
102 pulmonary alveolar microlithiasis 9.9
103 leber optic atrophy 9.9
104 kearns-sayre syndrome 9.9
105 brown syndrome 9.9
106 hydrops, lactic acidosis, and sideroblastic anemia 9.9
107 ocular albinism 9.9
108 persistent hyperplastic primary vitreous 9.9
109 autosomal dominant non-syndromic intellectual disability 1 9.9
110 sleeping sickness 9.9
111 trypanosomiasis 9.9
112 microphthalmia 9.9
113 synostosis 9.9
114 color blindness 9.9
115 cerebral palsy 9.9
116 craniosynostosis 9.9
117 corneal dystrophy 9.9
118 astrocytoma 9.9
119 macular retinal edema 9.9
120 familial retinoblastoma 9.9
121 peripheral nervous system disease 9.9
122 juvenile pilocytic astrocytoma 9.9
123 chickenpox 9.9
124 keratoconjunctivitis 9.9
125 neurofibroma 9.9
126 hypertropia 9.9
127 hypotropia 9.9
128 monofixation syndrome 9.9
129 pilocytic astrocytoma 9.9
130 syndromic craniosynostosis 9.9
131 pik3ca-related overgrowth syndrome 9.9
132 yemenite deaf-blind hypopigmentation syndrome 9.9
133 abducens palsy 9.8
134 adie pupil 9.8
135 alzheimer disease 9.8
136 anisocoria 9.8
137 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.8
138 catatrichy 9.8
139 coloboma of macula 9.8
140 deafness, unilateral 9.8
141 epicanthus 9.8
142 epidermoid cysts 9.8
143 hand skill, relative 9.8
144 attention deficit-hyperactivity disorder 9.8
145 lipomatosis, multiple 9.8
146 moebius syndrome 9.8
147 pernicious anemia 9.8
148 prader-willi syndrome 9.8
149 sturge-weber syndrome 9.8
150 chromosome 2q35 duplication syndrome 9.8
151 telecanthus 9.8
152 vitiligo-associated multiple autoimmune disease susceptibility 6 9.8
153 williams-beuren syndrome 9.8
154 autism 9.8
155 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.8
156 corneal dystrophy, band-shaped 9.8
157 myasthenia gravis 9.8
158 retinitis pigmentosa 9.8
159 retinoschisis of fovea 9.8
160 coats disease 9.8
161 retinoschisis 1, x-linked, juvenile 9.8
162 ataxia and polyneuropathy, adult-onset 9.8
163 stroke, ischemic 9.8
164 branchiootic syndrome 1 9.8
165 aceruloplasminemia 9.8
166 pars planitis 9.8
167 meningioma, radiation-induced 9.8
168 vitiligo-associated multiple autoimmune disease susceptibility 1 9.8
169 body mass index quantitative trait locus 1 9.8
170 meningioma, familial 9.8
171 myopia 6 9.8
172 myopia 9 9.8
173 human immunodeficiency virus type 1 9.8
174 leptin deficiency or dysfunction 9.8
175 carbonic anhydrase va deficiency, hyperammonemia due to 9.8
176 deficiency anemia 9.8
177 foodborne botulism 9.8
178 posterior polar cataract 9.8
179 brachydactyly 9.8
180 fetal alcohol spectrum disorder 9.8
181 metabolic acidosis 9.8
182 proximal symphalangism 9.8
183 autism spectrum disorder 9.8
184 aphasia 9.8
185 sclerocornea 9.8
186 cornea plana 9.8
187 anterior segment dysgenesis 9.8
188 fibrous dysplasia 9.8
189 neuroretinitis 9.8
190 pleomorphic lipoma 9.8
191 juvenile glaucoma 9.8
192 meningocele 9.8
193 amnestic disorder 9.8
194 hemiplegia 9.8
195 corneal edema 9.8
196 chlamydia 9.8
197 keratomalacia 9.8
198 pituitary apoplexy 9.8
199 arteriovenous malformation 9.8
200 lens subluxation 9.8
201 spinal meningioma 9.8
202 accommodative spasm 9.8
203 presbyopia 9.8
204 goiter 9.8
205 punctate epithelial keratoconjunctivitis 9.8
206 dysentery 9.8
207 entropion 9.8
208 locked-in syndrome 9.8
209 intermediate uveitis 9.8
210 quadriplegia 9.8
211 lagophthalmos 9.8
212 shipyard eye 9.8
213 alexia 9.8
214 irregular astigmatism 9.8
215 lacrimal duct obstruction 9.8
216 facial paralysis 9.8
217 methylmalonic acidemia 9.8
218 leber congenital amaurosis 9.8
219 cholera 9.8
220 conversion disorder 9.8
221 pulmonary tuberculosis 9.8
222 cellulitis 9.8
223 retinitis 9.8
224 articulation disorder 9.8
225 juvenile xanthogranuloma 9.8
226 hypotrichosis 9.8
227 secretory meningioma 9.8
228 lymphoplasmacyte-rich meningioma 9.8
229 endophthalmitis 9.8
230 somatoform disorder 9.8
231 movement disease 9.8
232 cavernous hemangioma 9.8
233 neurotic disorder 9.8
234 plexiform neurofibroma 9.8
235 retinal disease 9.8
236 cerebrovascular disease 9.8
237 placenta disease 9.8
238 corneal ulcer 9.8
239 night blindness 9.8
240 herpes simplex 9.8
241 learning disability 9.8
242 waardenburg's syndrome 9.8
243 exophthalmos 9.8
244 congenital nystagmus 9.8
245 meibomian cyst 9.8
246 adamtsl4-related eye disorders 9.8
247 isolated methylmalonic acidemia 9.8
248 anterior uveitis 9.8
249 encephalocele 9.8
250 neonatal stroke 9.8
251 vernal keratoconjunctivitis 9.8
252 weber syndrome 9.8
253 woolly hair syndrome 9.8
254 depression 9.8
255 dysphagia 9.8
256 headache 9.8
257 traumatic brain injury 9.8
258 basal encephalocele 9.8
259 spasmus nutans 9.8
260 cyanide poisoning 9.8
261 juvenile myasthenia gravis 9.8
262 extensive peripapillary myelinated nerve fibers 9.8
263 digitalis poisoning 9.8

Graphical network of the top 20 diseases related to Suppression Amblyopia:



Diseases related to Suppression Amblyopia

Symptoms & Phenotypes for Suppression Amblyopia

UMLS symptoms related to Suppression Amblyopia:


photophobia, other specified visual disturbances, visual disturbance

GenomeRNAi Phenotypes related to Suppression Amblyopia according to GeneCards Suite gene sharing:

26 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance GR00327-A 8.62 APTX GRM6

Drugs & Therapeutics for Suppression Amblyopia

Drugs for Suppression Amblyopia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 109, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tropicamide Approved, Investigational Phase 4 1508-75-4 5593
2
Atropine Approved, Vet_approved Phase 4 5908-99-6, 51-55-8 174174
3
Donepezil Approved Phase 4 120014-06-4 3152
4
Brinzolamide Approved Phase 4 138890-62-7 68844
5
Nepafenac Approved, Investigational Phase 4 78281-72-8 151075
6
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
7
Cefpirome Approved Phase 4 84957-29-9 5479539
8
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
9
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
10
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
11
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
12
Polyestradiol phosphate Approved Phase 4 28014-46-2
13
Sotalol Approved Phase 4 959-24-0, 3930-20-9 5253
14 Mydriatics Phase 4
15 Parasympatholytics Phase 4
16 Adjuvants, Anesthesia Phase 4
17 Cholinergic Antagonists Phase 4
18 Muscarinic Antagonists Phase 4
19 Respiratory System Agents Phase 4
20 Anti-Asthmatic Agents Phase 4
21 Bronchodilator Agents Phase 4
22 Nootropic Agents Phase 4
23 Cholinesterase Inhibitors Phase 4
24 Ophthalmic Solutions Phase 4
25 Anti-Inflammatory Agents Phase 4
26 Carbonic Anhydrase Inhibitors Phase 4
27 Analgesics Phase 4
28 Cyclooxygenase Inhibitors Phase 4
29 Analgesics, Non-Narcotic Phase 4
30 Anti-Inflammatory Agents, Non-Steroidal Phase 4
31 Ketorolac Tromethamine Phase 4
32 Antirheumatic Agents Phase 4
33 Contraceptives, Oral Phase 4
34 Contraceptive Agents Phase 4
35 Contraceptives, Oral, Combined Phase 4
36 Norgestimate, ethinyl estradiol drug combination Phase 4
37 Anti-Bacterial Agents Phase 4
38 Cephalosporins Phase 4
39 Anti-Infective Agents Phase 4
40 Antibiotics, Antitubercular Phase 4
41 Topoisomerase Inhibitors Phase 4
42 Estradiol 3-benzoate Phase 4
43 Estradiol 17 beta-cypionate Phase 4
44 Peripheral Nervous System Agents Phase 4
45 Autonomic Agents Phase 4
46 Sodium Channel Blockers Phase 4
47 Diuretics, Potassium Sparing Phase 4
48 Sympatholytics Phase 4
49
Levodopa Approved Phase 3 59-92-7 6047
50
Carbidopa Approved Phase 3 28860-95-9 34359
51
Guaifenesin Approved, Investigational, Vet_approved Phase 2, Phase 3 93-14-1 3516
52
Acetaminophen Approved Phase 2, Phase 3 103-90-2 1983
53
Acetazolamide Approved, Vet_approved Phase 2, Phase 3 59-66-5 1986
54
Codeine Approved, Illicit Phase 2, Phase 3 76-57-3 5284371
55
Naproxen Approved, Vet_approved Phase 2, Phase 3 22204-53-1 1302 156391
56
Ibuprofen Approved Phase 2, Phase 3 15687-27-1 3672
57
Aspirin Approved, Vet_approved Phase 2, Phase 3 50-78-2 2244
58 Antiparkinson Agents Phase 3
59 Aromatic Amino Acid Decarboxylase Inhibitors Phase 3
60 Central Nervous System Depressants Phase 2, Phase 3
61 Narcotics Phase 2, Phase 3
62 Fibrinolytic Agents Phase 2, Phase 3
63 diuretics Phase 2, Phase 3
64 Natriuretic Agents Phase 2, Phase 3
65 Chlorpheniramine, phenylpropanolamine drug combination Phase 2, Phase 3
66 Analgesics, Opioid Phase 2, Phase 3
67 Platelet Aggregation Inhibitors Phase 2, Phase 3
68 Anticonvulsants Phase 2, Phase 3
69 Antitussive Agents Phase 2, Phase 3
70 Antipyretics Phase 2, Phase 3
71
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
72 Micronutrients Phase 2
73 Trace Elements Phase 2
74 Vitamins Phase 2
75 Vitamin B9 Phase 2
76 Folate Phase 2
77 Nutrients Phase 2
78 Vitamin B Complex Phase 2
79 Omega 3 Fatty Acid Phase 1, Phase 2
80
Maleic acid Experimental, Investigational Phase 1 110-17-8, 110-16-7 444972
81
Calcium carbonate Approved, Investigational 471-34-1
82 Tomato Approved
83
Dexamethasone Approved, Investigational, Vet_approved 50-02-2 5743
84
Dexamethasone acetate Approved, Investigational, Vet_approved 1177-87-3
85
Dopamine Approved 51-61-6, 62-31-7 681
86
Cocaine Approved, Illicit 50-36-2 446220 5760
87
Acetylcholine Approved, Investigational 51-84-3 187
88
Methamphetamine Approved, Illicit 537-46-2 10836
89 Curare
90 Antioxidants
91 Protective Agents
92 Gastrointestinal Agents
93 Antiemetics
94 HIV Protease Inhibitors
95 glucocorticoids
96 Hormones
97
protease inhibitors
98 Antineoplastic Agents, Hormonal
99 Hormone Antagonists
100 BB 1101
101 Hormones, Hormone Substitutes, and Hormone Antagonists
102 Dopamine Agents
103 Anesthetics
104 Cholinergic Agents
105 Acetylcholine Release Inhibitors
106 Botulinum Toxins
107 Sympathomimetics
108 Neurotransmitter Uptake Inhibitors
109 Dopamine Uptake Inhibitors

Interventional clinical trials:

(showing 145, show less)
# Name Status NCT ID Phase Drugs
1 Pilot Study of Prevention Myopia in Children With Low Concentration of Atropine Unknown status NCT00541177 Phase 4 atropine;tropicamide
2 The Effect of Donepezil on Perceptual Learning in Adult Amblyopia Completed NCT03109314 Phase 4 Donepezil
3 A Randomized Trial Comparing Daily Atropine Versus Weekend Atropine Completed NCT00094614 Phase 4 Atropine
4 Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome Completed NCT01312402 Phase 4 topical brinzolamide 1% in 5mL ophthalmic medication;Placebo in 5 mL dispenser
5 Mini-flared Kelman Tip and Reverse Tip With Torsional Phaco: Prospective Randomized Comparative Study Completed NCT02089698 Phase 4
6 Comparison of Ketorolac Tromethamine 0.4% and Nepafenac 0.1% for the Prevention of Cystoid Macular Edema After Phacoemulsification: Prospective Randomized Double-masked Study Completed NCT02084576 Phase 4 Nepafenac;Ketorolac
7 Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration Completed NCT00280514 Phase 4 cefpirome and moxifloxacin administration
8 A Pilot and Feasibility Study to Determine if a Common Atrial Fibrillation Risk Locus Modulates Differential Response to Antiarrhythmic Drugs Recruiting NCT02347111 Phase 4 Flecainide;Sotalol
9 Topical Timolol for the Treatment of Benign Vascular Periocular Lesions Withdrawn NCT01250457 Phase 4 topical Timolol
10 Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation Withdrawn NCT00366613 Phase 4
11 Vision In Preschoolers Study (VIP Study) Unknown status NCT00038753 Phase 3
12 Anisometropia Amblyopia Improved by Perceptual Learning and Patching Completed NCT00498641 Phase 3
13 A Randomized Trial of Levodopa as Treatment for Residual Amblyopia (ATS 17) Completed NCT01190813 Phase 3 Levodopa/Carbidopa;Placebo
14 A Randomized Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia Completed NCT00094679 Phase 3
15 Increasing Patching for Amblyopia in Children 3 to < 8 Years Old Completed NCT00945100 Phase 3
16 A Randomized Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old Completed NCT00315198 Phase 3
17 A Randomized Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye As Prescribed Treatments for Amblyopia in Children 3 to <7 Years Old Completed NCT00315302 Phase 3 Atropine
18 A Randomized Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia Completed NCT00094744 Phase 3
19 Electronic Recording of Compliance With Occlusion Therapy for Amblyopia: 1 Effects of Patient Education on Compliance 2 Predictors for Non-Compliance Completed NCT00131729 Phase 3
20 Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia Completed NCT00000170 Phase 3 Atropine
21 Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old Completed NCT00944710 Phase 3 Atropine;Atropine
22 An Evaluation of Treatment of Amblyopia in 7 To <18 Year Olds Completed NCT00094692 Phase 3 atropine
23 Amblyopia Treatment Study Completed NCT00001864 Phase 3 Atropine
24 A Randomized Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children 3 to <7 Years Old Completed NCT00091923 Phase 3
25 A Randomized Trial of Full-time Bangerter Filters Versus Part-time Daily Patching for the Treatment of Moderate Amblyopia in Children Completed NCT00525174 Phase 3
26 A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds Completed NCT00315328 Phase 3 Atropine
27 Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity Completed NCT01203436 Phase 2, Phase 3
28 A Multicenter, Double-blind, Randomized, Placebo-controlled Study of Weight-Reduction and/or Low Sodium Diet Plus Acetazolamide vs Diet Plus Placebo in Subjects With Idiopathic Intracranial Hypertension With Mild Visual Loss Completed NCT01003639 Phase 2, Phase 3 Acetazolamide;Placebo
29 A Randomized Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia in Children 7 to <13 Years Old Terminated NCT00587171 Phase 3
30 A Randomized Trial to Evaluate Combined Patching-Atropine for Residual Amblyopia Terminated NCT00506675 Phase 3 Atropine;Atropine
31 A Novel Therapeutic Strategy Targeting Photoreceptor Oxidative Damage in ABCR-related Retinal Degenerations Unknown status NCT01278277 Phase 1, Phase 2
32 Is Non-cycloplegic Photorefraction Applicable for Screening Refractive Risk Factors of Amblyopia? Completed NCT01308307 Phase 2
33 A Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia in 8 to 17 Year Olds Completed NCT00789672 Phase 2 levodopa/carbidopa;levodopa/carbidopa
34 Effectiveness of Telescopic Magnification in the Treatment of Amblyopia Completed NCT00970554 Phase 1, Phase 2
35 Evaluation and Development of a Novel Binocular Treatment (I-BiTTM) System Using Video Clips and Interactive Games to Improve Vision in Children With Amblyopia ('Lazy Eye'). Completed NCT01702727 Phase 2
36 Comparison of Photorefraction With Cycloautorefraction and Cycloretinoscopy at Emam Hosein Medical Centre in 2008-2009 Completed NCT00815581 Phase 1, Phase 2
37 Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants Completed NCT00349726 Phase 2 Inositol lower volume;Inositol higher volume;Placebo lower volume;Placebo higher volume
38 Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants Completed NCT01030575 Phase 2 Inositol lower volume;Inositol mid-level volume;Inositol high volume;Placebo low volume
39 THOR - Tübingen Choroideremia Gene Therapy Trial Open Label Phase 2 Clinical Trial Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1) Active, not recruiting NCT02671539 Phase 2
40 Pilot Study to Evaluate Docosahexaenoic Acid as Treatment for Residual Amblyopia Not yet recruiting NCT03402789 Phase 1, Phase 2 Docosahexaenoic Acid;Placebo Oral Tablet
41 Caffeine in Amblyopia Study Withdrawn NCT02594358 Phase 1, Phase 2 Caffeine
42 Randomised Occlusion Treatment of Amblyopia Study (ROTAS): Trial of Maximal Vs Substantial Doses of Occlusion to Evaluate Visual Outcome for Children With Amblyopia Completed NCT00274664 Phase 1
43 Investigation of Visual Plasticity by a Direct Current Stimulation of Occipital Cortex in Adult Amblyopia Completed NCT00097162 Phase 1
44 A Singapore Pilot Study To Evaluate The Efficacy Of A Computerized System For The Vision Improvement Of People With Low Myopia Completed NCT00348127 Phase 1
45 Monovision for Treatment of Diplopia Completed NCT01426672 Phase 1
46 Pilot Study To Evaluate The Efficacy Of Neurovision'S NVC™- Vision Correction Technology For The Improvement In Visual Acuity In Myopic Children And Slowing Down Of Myopia Progression Completed NCT00348218 Phase 1
47 Recovery From Amblyopia With Cholinesterase Inhibitors Recruiting NCT01584076 Phase 1 Donepezil
48 Dichoptic Virtual Reality Therapy for Amblyopia in Adults Terminated NCT02246556 Phase 1
49 Phase 1 Study of Topical Beta Blocker to Prevent the Proliferative Stage of Infantile Hemangioma Terminated NCT01434849 Phase 1 topical 0.5% Timolol maleate;Control (placebo) group
50 Early Vision Screening With Automated Photorefraction in Pre-term, Low-birth- Weight and Development-delay Children in Far-Eastern Memorial Hospital, Taiwan Unknown status NCT02678468
51 Determining the Efficacy of Full-time Occlusion Therapy in Severe Amblyopia at All Ages Unknown status NCT02113709
52 The Role of Interactive Binocular Treatment System in Amblyopia Therapy Unknown status NCT02740725
53 The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years Unknown status NCT02810847
54 Optimized Visual Recovery in Adult Human Amblyopia Through Binocular Deprivation Unknown status NCT02685423
55 New Pediatric Patching Method to Improve Compliance Unknown status NCT02236351
56 An Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old Completed NCT00669539
57 Refractive and Strabismic Amblyopia Risk Factors Detected by Infrared Photoscreener and School Bus Skiascopy Completed NCT03668067
58 Standard Amblyopia Therapy in Adult Amblyopes Completed NCT03341780
59 Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children Completed NCT03447171
60 Pediatric Vision Scanner for the Eradication of Amblyopia Completed NCT01726842
61 Validation of a Questionnaire Assessing Quality of Life in Children With Amblyopia and Strabismus Completed NCT02880488
62 Assessment of Device for Treatment of Amblyopia Completed NCT02003235
63 Analysis of Spectral Domain Optical Coherence Tomography Measurements in Amblyopia Completed NCT01179763
64 Prospective Evaluation of a Smartphone Application, GoCheckKids™ as a Photo Screening Tool in a Pediatric Population Completed NCT03119675
65 Pediatric Vision Scanner 4 (PVS4) Completed NCT01832883
66 Luminopia VR Device Pilot Study Completed NCT02782117
67 MEPEDS New Device Pediatric Vision Scanner Completed NCT01706991
68 Does Video Game Play Induce Plasticity in the Visual System of Adults With Amblyopia? Completed NCT01223716
69 Vision Screening of the Four Year Old Children for the Detection of Amblyopia in The Town of Zagreb Completed NCT01430247
70 Multimodal Physician Intervention to Detect Amblyopia (Recruiting Title "Equipping Primary Care Physicians to Improve Care for Children") Completed NCT01109459
71 Study of Binocular Computer Activities for Treatment of Amblyopia Completed NCT02200211
72 Efficacy of Over-glasses Patch Treatment for Amblyopia in Children :OPTA Study, A Prospective Randomized Clinical Trial Completed NCT03080285
73 Amblyopia and Strabismus Testing in Pediatrics Completed NCT02536963
74 Analysis of Retinal Nerve Fiber Layer and Macular Thickness After Congenital Cataract Surgery Completed NCT03621579
75 Bilateral Refractive Amblyopia Treatment Study Completed NCT00305955
76 Glasses Versus Observation for Moderate Hyperopia in Young Children (HTS1) Completed NCT01515475
77 Disinvestment Study of Population-Based Vision Screening in Preverbal Children in the Netherlands Completed NCT01675193
78 AquaLase Capsule Wash for Pediatric Eyes Completed NCT00756327
79 Evaluation of a Visual Acuity Testing Software for Children, VisionQuest 20/20 Completed NCT00366756
80 Binocular Treatment of Amblyopia Before and After Strabismus Surgery Completed NCT01791946
81 Evaluation and Treatment Protocol for Patients With Pediatric Eye Diseases and Strabismus Completed NCT00006422
82 Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis Completed NCT02843438 Anti-toxoplasmosis treatment;Anti-inflammatory treatments
83 A Long-term Postoperative Outcome After Bilateral Congenital Cataract Surgery in Eyes With Microphthalmos Completed NCT01818037
84 Test-Retest Variability of Quick Contrast Sensitivity Function Testing Completed NCT02177669
85 Visual Performance of New Apodized Diffractive Multifocal IOL With Addition of Plus Three Completed NCT01027533
86 Visual Outcomes After Implantation of a Segmental Refractive Multifocal Intraocular Lens Following Cataract Surgery Completed NCT03452969
87 Effect of Neuromuscular Blockade on the Oculomotor by Not Squinting Child Completed NCT02360969
88 Antioxidant Systems and Age-Related Macular Degeneration Completed NCT00668213
89 Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos AO Intraocular Lens Implantation: Clinical Comparative Study Completed NCT00863759
90 Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Nystagmus or Strabismus Completed NCT00001861
91 Assessing the Functional and Psychosocial Impact of Strabismus in Asian Children Using the AS-20 and IXTQ Questionnaires Completed NCT01608828
92 Effect of the Timing of Lens-removal Cataract Surgery on Postoperative Complications Rate Among Patients With Bilateral Congenital Cataracts Completed NCT02581046 Subconjunctival dexamethasone and general anesthesia
93 Tertiary Care Based Visual Developmental Diseases Management Model Among Preschool Children in China: a Cluster Randomized Controlled Trial Completed NCT03251456
94 Effect of a Mobile Phone Short Message Service (SMS) on Childhood Cataract Follow-up Adherence in China Completed NCT01417819
95 A Novel Acuity Testing Method Completed NCT00013936
96 Congenital Esotropia Observational Study (CEOS) Completed NCT00000163
97 Evaluation of Refractive Status and Ophthalmological Problems of Prematurity Completed NCT01045616
98 Augmented Medial Rectus Muscle Recession Versus Medial Rectus Recession With Posterior Scleral Fixation in Partially Accommodative Esotropia Completed NCT02413463
99 Evaluation of Choroidal Thickness Using Spectral Optical Coherence Tomography in Pseudoexfoliation Glaucoma and Primary Open Angle Glaucoma Completed NCT03373942
100 Evaluation of the Acrysof Toric SN60T3 Intraocular Lens in Patients With Predicted Residual Corneal Astigmatism Between 0.75 and 1.00 D. Completed NCT00542581
101 Examination of New Visual Acuity and Clinical Crowding Tests for Better Detection of Amblyopia Recruiting NCT03505606
102 Augmenting Patching Treatment for Amblyopia With Physical Exercise Recruiting NCT03822806
103 Binocular Dig Rush Game Treatment for Amblyopia Recruiting NCT02983552
104 Objective Adherence With Optical Correction in Children With Bilateral and Unilateral Refractive Amblyopia Recruiting NCT03780205
105 Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia Recruiting NCT02687581
106 Intense vs Standard Regimens of Intermittent Occlusion Therapy for Unilateral Moderate Amblyopia in Children Recruiting NCT02767856
107 Treating Amblyopia in Adults With Interactive Video Games Recruiting NCT03906994
108 Dichoptic Video Treatment for Amblyopia in Children Age 3-7 Years Recruiting NCT03825107
109 Binocular Amblyopia Treatment Recruiting NCT03288948
110 Improving Spatial and Temporal Vision in Adult and Juvenile Amblyopia Recruiting NCT01115283
111 Towards Developing a Perceptual Learning Treatment for Amblyopia Recruiting NCT03788031
112 Feasibility and Efficacy of Transcorneal Electrical Stimulation (TES) for the Treatment of Amblyopia Recruiting NCT02495935
113 Binocular iPad Sub-Study; Suppression in Amblyopia Recruiting NCT02365090
114 A Comparative Study Between Dissociative Treatment and Binocular Interactive Treatment in Amblyopia Recruiting NCT03255707
115 Photorefractive Keratectomy for Anisometropic and Isoametropic Amblyopia in Children Refractory to Conventional Treatment Recruiting NCT03610997
116 Neurovascular Coupling in Subjects With Amblyopia Recruiting NCT01746693
117 Binocular Visual Therapy and Video Games for Amblyopia Treatment. Recruiting NCT03655912
118 A Randomised Clinical Trial Objectively Comparing the Effect of Patching Therapy With Video Gaming for Amblyopia Recruiting NCT03767985
119 Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences Recruiting NCT03940222
120 MRI-based Biomarkers for the Prognosis Judgement of Punctate White Matter Lesions in Neonates: a Longitudinal Multicenter Study Recruiting NCT02637817
121 The Efficacy of a Visual Screening Program to Reduce Later Amblyopia and Untreated Refractive Errors Recruiting NCT02458846
122 Mobile Medical Application for Cost-effective Strabismus Screening Recruiting NCT03450980
123 The Effects of Regular Eye-training With a Mobile Device on Adult Patients With AMD Recruiting NCT03461393
124 The Effect of Peripheral Defocus on Axial Growth and Modulation of Refractive Error in Hyperopes Recruiting NCT02686879
125 Monofocal Extended Range of Vision (MERoV) Study Recruiting NCT04011696
126 Efficacy of Coloured Overlays and Lenses for Adults With Reading Difficulty Recruiting NCT02680223
127 Will Perceptual Learning Via Video Game Playing Improve Visual Acuity, Stereopsis and Fixation Stability in Mild Amblyopes? Part 2 Study Active, not recruiting NCT02995174
128 The Long-Term Efficacy of Overminus Lens Therapy in Intermittent Exotropia Active, not recruiting NCT03952702
129 Use of Multifocal Contact Lenses to Stimulate Axial Elongation in Axial Hyperopia Active, not recruiting NCT00950924
130 A Randomized Trial of Bilateral Lateral Rectus Recession Versus Unilateral Lateral Rectus Recession With Medial Rectus Resection for Intermittent Exotropia Active, not recruiting NCT01032603
131 Visual Functional Connectivity and Visual Function in Amblyopia Before and After TMS and/or Binocular Treatment Enrolling by invitation NCT03151200
132 Improving Visual Functions in Young Children With Amblyopia Through Perceptual Learning Not yet recruiting NCT02555384
133 Efficacy and Safety of Eyetronix Flicker Glasses to the Treatment of Anisometropic Amblyopia in Chinese Children Not yet recruiting NCT02970708
134 The Effect of Light Deprivation on Visual Functions in Adult Amblyopes Not yet recruiting NCT02799836
135 The Research of the Neural Mechanisms Underlying Astigmatism Not yet recruiting NCT03735602
136 Deploying Retinal Birefringence Imaging in to the Clinic for Pediatric Vision Screening Not yet recruiting NCT03919708
137 Excimer Laser Surgery for Anisometropic Amblyopia Not yet recruiting NCT03342235
138 Phase 2a Two-site Randomised Controlled Trial to Determine Safety of and Adherence With a New 'Binocularly Balanced Viewing' Treatment for Unilateral Amblyopia Compared With Standard Treatment in Children Age 3-8 Years Not yet recruiting NCT03754153
139 Müller's Muscle as a New Proprioceptive Organ Evidence From Immunohistochemical Staining and Electron Microscopy to Verify That the Upper Eyelid Müller's Muscle Contains Proprioceptive Innervation for Reflexive Correction of Eyelid Position Not yet recruiting NCT03396627
140 Botulinum Toxin Augmented Surgery Versus Conventional Surgery in the Management of Large Angle Infantile Esotropia Not yet recruiting NCT03266549
141 Use of a Novel, Objective Optokinetic Contrast Device to Determine Scotopic Range Visual Function and Discriminate Between Patients With and Without Glaucoma Suspended NCT02014597
142 Comparison of AmblyzTM Glasses and Patching for Amblyopia Terminated NCT01973348
143 Randomized Clinical Trial of OCT-guided Laser-assisted Lamellar Anterior Keratoplasty in Children Terminated NCT01579643
144 Amblyopia and Neurovascular Coupling in the Retina of Humans Withdrawn NCT00312390
145 Évaluation de l'Utilisation d'un Photoscreener Comme méthode de dépistage Des problèmes Ophtalmologiques pédiatriques en Haïti Withdrawn NCT02655432

Search NIH Clinical Center for Suppression Amblyopia

Cochrane evidence based reviews: amblyopia

Genetic Tests for Suppression Amblyopia

Anatomical Context for Suppression Amblyopia

MalaCards organs/tissues related to Suppression Amblyopia:

41
Eye, Testes, Cortex, Brain, Retina, Endothelial, Pituitary

Publications for Suppression Amblyopia

Articles related to Suppression Amblyopia:

(showing 6917, show less)
# Title Authors PMID Year
1
tDCS recovers depth perception in adult amblyopic rats and reorganizes visual cortex activity. 38
31078617 2019
2
Bilateral Congenital Corneal Opacities as an Early-Onset Ocular Feature of Kabuki Syndrome. 38
30950893 2019
3
Simplified updates on the pathophysiology and recent developments in the treatment of amblyopia: A review. 38
31436180 2019
4
Biometry: a tool for the detection of amblyopia risk factor in children. 38
31183540 2019
5
[An investigation on professional performance of optometric refraction in spectacles stores in Anyang city of Henan Province]. 38
31422635 2019
6
Analysis of Choroidal Vascularity in Children with Unilateral Hyperopic Amblyopia. 38
31434959 2019
7
Amblyopia Affects the ON Visual Pathway More than the OFF. 38
31189574 2019
8
Effects of Temporal Frequency on Binocular Deficits in Amblyopia. 38
31404553 2019
9
Morphologic changes in the visual cortex of patients with anisometropic amblyopia: a surface-based morphometry study. 38
31375091 2019
10
Analysis of Macular Vessel Density and Foveal Avascular Zone in Adults with Amblyopia. 38
31283893 2019
11
Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens. 38
31429729 2019
12
Comparison of amblyopia in schoolchildren in Ireland and Northern Ireland: a population-based observational cross-sectional analysis of a treatable childhood visual deficit. 38
31401612 2019
13
Factors determining the outcome of paediatric exotropia surgery. 38
31424031 2019
14
Study on the High Functional Contact Lens Material with Superior Oxygen Transmissibility and Antibacterial Properties. 38
30913731 2019
15
Ocular dominance plasticity: A binocular combination task finds no cumulative effect with repeated patching. 38
31194984 2019
16
Novel BRPF1 mutation in a boy with intellectual disability, coloboma, facial nerve palsy and hypoplasia of the corpus callosum. 38
31176769 2019
17
Cost-Effectiveness of Limited Vitrectomy for Vision-Degrading Myodesopsia. 38
30849342 2019
18
Assessment of stereovision with digital testing in adults and children with normal and impaired binocularity. 38
31377344 2019
19
[Orbital Disorders in Childhood]. 38
31412385 2019
20
Impaired Fellow Eye Motion Perception and Abnormal Binocular Function. 38
31387113 2019
21
Referral for Ophthalmology Evaluation and Visual Sequelae in Children With Primary Brain Tumors. 38
31373649 2019
22
Foveal avascular zone and macular vessel density after correction for magnification error in unilateral amblyopia using optical coherence tomography angiography. 38
31382925 2019
23
Prevalence of anterior polar cataracts in children and risk factors for amblyopia. 38
30390373 2019
24
The effect of asymmetrical accommodation on anisometropic amblyopia treatment outcomes. 38
31301347 2019
25
Video interpretation and diagnosis of pediatric amblyopia and eye disease. 38
31364472 2019
26
Regression of fetal vasculature and visual improvement in nonsurgical persistent hyperplastic primary vitreous: a case report. 38
31349817 2019
27
The Outcome of Scleral Lens Fitting for Keratoconus With Resolved Corneal Hydrops. 38
31170103 2019
28
Fellow Eye Deficits in Amblyopia. 38
31161888 2019
29
A Convenient and Robust Test to Quantify Interocular Suppression for Children With Amblyopia. 38
31384415 2019
30
Amblyopia treatment and quality of life: the child's perspective on atropine versus patching. 38
31329017 2019
31
Feasibility of monitoring compliance with intermittent occlusion therapy glasses for amblyopia treatment. 38
31271842 2019
32
Analysis of retinal nerve fiber layer thickness in anisometropic amblyopia via optic coherence tomography. 38
31270595 2019
33
Dichoptic De-Masking Learning in Adults With Amblyopia and Its Mechanisms. 38
31307059 2019
34
Optical Coherence Tomography normative peripapillary retinal nerve fiber layer and macular data in children ages 0-5 years. 38
31271744 2019
35
Sex-specific difference in age distribution of congenital lower eyelid epiblepharon in a Japanese population. 38
31286315 2019
36
Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus? 38
31296236 2019
37
Oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. 38
30783259 2019
38
Visual Acuity and Ophthalmic Outcomes in the Year After Cataract Surgery Among Children Younger Than 13 Years. 38
31095258 2019
39
Analysis of macular, foveal, and retinal nerve fiber layer thickness in children with unilateral anisometropic amblyopia and their changes following occlusion therapy. 38
31238399 2019
40
Commentary: Analysis of macular, foveal and retinal nerve fiber layer thickness in children with unilateral anisometropic amblyopia and their changes following occlusion therapy. 38
31238400 2019
41
Comparison of higher order aberrations in amblyopic and non-amblyopic eyes in pediatric patients with anisometropic amblyopia. 38
31238401 2019
42
Binocular game versus part-time patching for treatment of anisometropic amblyopia in Chinese children: a randomised clinical trial. 38
31272953 2019
43
Don't Miss This! Red Flags in the Pediatric Eye Examination: Subnormal Acuity. 38
31329058 2019
44
OCT angiography of persistent hyaloid artery: a case report. 38
31272412 2019
45
A commonly occurring genetic variant within the NPLOC4-TSPAN10-PDE6G gene cluster is associated with the risk of strabismus. 38
31073882 2019
46
Comparative study of visual dysfunctions in 6-10-year-old very preterm- and full-term-born children. 38
29916121 2019
47
Expanding the phenotypic spectrum of MBOAT7-related intellectual disability. 38
31282596 2019
48
Tribal Odisha Eye Disease Study (TOES) report # 5: Comparison of prevalence and causes of visual impairment among tribal children in native and urban schools of Odisha (India). 38
31238398 2019
49
Visual outcome and surgical results in children with Marfan syndrome. 38
31325202 2019
50
Clinical investigation plan for the use of interactive binocular treatment (I-BiT) for the management of anisometropic, strabismic and mixed amblyopia in children aged 3.5-12 years: a randomised controlled trial. 38
31311577 2019
51
Duane's Retraction Syndrome in a Cohort of South African Children: A 20-Year Clinic-Based Review. 38
31322716 2019
52
Diagnostic test accuracy of Spot and Plusoptix photoscreeners in detecting amblyogenic risk factors in children: a systemic review and meta-analysis. 38
31236980 2019
53
Does successful surgical correction of childhood large angle exotropia in adults make any difference to binocularity and quality of life? 38
31335253 2019
54
Treatment of amblyopia: part 4. 38
31134846 2019
55
Binocular amblyopia treatment with contrast-rebalanced movies. 38
31103562 2019
56
Audiovisual perception in amblyopia: A review and synthesis. 38
29758189 2019
57
Long-term Effects After Pediatric LASIK for Anisometropic Amblyopia in Two Patients. 38
31185105 2019
58
[Syndrome of bilateral myelinated retinal nerve fibers, myopia and amblyopia: A case report]. 38
31182255 2019
59
Refinement of the Child Amblyopia Treatment Questionnaire (CAT-QoL) using Rasch analysis. 38
31012391 2019
60
Suprathreshold Motion Perception in Anisometropic Amblyopia: Interocular Speed Matching and the Pulfrich Effect. 38
31107841 2019
61
Amblyopia therapy in Asian children: factors affecting visual outcome and parents' perception of children's attitudes towards amblyopia treatment. 38
30488078 2019
62
The effect of different amblyopia treatment protocols on axial length of non-amblyopic eyes in anisohyperopic patients. 38
31317100 2019
63
Microvascular changes in amblyopic eyes detected by optical coherence tomography angiography. 38
31004783 2019
64
Corneal indices following photorefractive keratectomy in children at least 5 years after surgery. 38
31103563 2019
65
False corneal ectasia in patients referred for corneal crosslinking, topography-guided photorefractive keratectomy, and intrastromal corneal rings. 38
31109479 2019
66
The treatment of amblyopia: current practice and emerging trends. 38
30706134 2019
67
Zone of retinal vascularization and refractive error in premature eyes with and without spontaneously regressed retinopathy of prematurity. 38
31229607 2019
68
Refractive, sensory, and biometric outcome among retinopathy of prematurity children with a history of laser therapy: A retrospective review from a tertiary care center in South India. 38
31124505 2019
69
Altered brain activity in patients with strabismus and amblyopia detected by analysis of regional homogeneity: A resting‑state functional magnetic resonance imaging study. 38
31059016 2019
70
Outcomes following surgery for horizontal strabismus in children of lower socioeconomic backgrounds. 38
31184517 2019
71
A clinicopathological study of persistent fetal vasculature. 38
31124487 2019
72
Vision and visual potential for perifoveal retinoblastoma after optical coherence tomographic-guided sequential laser photocoagulation. 38
29976784 2019
73
Fixation instability during binocular viewing in anisometropic and strabismic children. 38
30006273 2019
74
[Ametropia among senegalese children in a hospital setting]. 38
31235321 2019
75
Status of visual impairment among indigenous (Orang Asli) school children in Malaysia. 38
31196018 2019
76
Factors influencing stereopsis in patients with both refractive accommodative esotropia and amblyopia. 38
29704131 2019
77
Plusoptix photoscreener use for paediatric vision screening in Flanders and Iran. 38
31197950 2019
78
The history of the Ostschweizerische Pleoptik und Orthoptik Schule in St. Gallen. 38
31151365 2019
79
Patterns of uveitis in children according to age: comparison of visual outcomes and complications in a tertiary center. 38
31248388 2019
80
The absence of fundus abnormalities in Stargardt disease. 38
30903310 2019
81
Updates on managements of pediatric cataract. 38
31317088 2019
82
Characteristic patterns of segmental infantile hemangiomas in Indian children: A descriptive study. 38
31169257 2019
83
The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity. 38
31078540 2019
84
Intraocular lens implantation in children with unilateral congenital cataract in the first 4 years of life. 38
30060694 2019
85
PARS PLANA VITRECTOMY WITH ANTERIOR CHAMBER VERSUS GORE-TEX SUTURED POSTERIOR CHAMBER INTRAOCULAR LENS PLACEMENT: Long-Term Outcomes. 38
29346243 2019
86
Quantitative analysis of retinal microcirculation in children with hyperopic anisometropic amblyopia: an optical coherence tomography angiography study. 38
31112776 2019
87
Comparison of the CAT-QoL and PedsQLTM instruments in measuring quality of life in amblyopia treatment: preliminary results. 38
31120350 2019
88
The impact of vision screening in preschool children on visual function in the Swedish adult population. 38
31127702 2019
89
Clarifications to Consider Regarding Multiple-Choice Answer Form Completion Time in Children With Amblyopia and Strabismus. 38
30844020 2019
90
Performance Of The 2win Photoscreener With "Cr" Strabismus Estimation In High Risk Patients. 38
31077668 2019
91
Functional limitations recognised by adults with amblyopia and strabismus in daily life: a qualitative exploration. 38
30957266 2019
92
Clarifications to Consider Regarding Multiple-Choice Answer Form Completion Time in Children With Amblyopia and Strabismus-Reply. 38
30844066 2019
93
Visual improvement in amblyopic eye following treatment-induced vision loss in dominant eye with uveal melanoma. 38
31097438 2019
94
[Features of clinical application of eye acupuncture therapy revealed by data mining]. 38
31155873 2019
95
Congenital glycosylation disorder: a novel presentation of coexisting anterior and posterior segment pathology and its implications in pediatric cataract management. 38
31153949 2019
96
Amblyopia Elimination Project: Pediatric Medical Home-Based Community Vision Screening. 38
31116860 2019
97
Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice. 38
31048900 2019
98
Self-perception in Children Aged 3 to 7 Years With Amblyopia and Its Association With Deficits in Vision and Fine Motor Skills. 38
30763432 2019
99
Two cortical deficits underlie amblyopia: A multifocal fMRI analysis. 38
28943411 2019
100
Treatment outcomes for amblyopia using PEDIG amblyopia protocols: a retrospective study of 877 cases. 38
30935990 2019
101
Pediatric keratoconus misdiagnosed as meridional amblyopia. 38
30900595 2019
102
Gap effect and express saccades generation in amblyopia. 38
30977772 2019
103
Assessment of macular vascular plexus density using optical coherence tomography angiography in cases of strabismic amblyopia. 38
30900586 2019
104
Binocular treatment in adult amblyopia is based on parvocellular or magnocellular pathway. 38
31014078 2019
105
Comparing Three Different Contrast Sensitivity Tests in Adults and in Children with and without Amblyopia. 38
30999326 2019
106
Binocular vision and fixational eye movements. 38
30943531 2019
107
White matter microstructural alterations in amblyopic adults revealed by diffusion spectrum imaging with systematic tract-based automatic analysis. 38
29844086 2019
108
Early isolated optic neuropathy caused by cyclosporine. 38
29532216 2019
109
Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick. 38
30134449 2019
110
Visual outcomes and complications of congenital cataract surgery. 38
30898370 2019
111
Pediatric Periocular Dermoid Cysts: Incidence, Clinical Characteristics, and Surgical Outcomes. 38
30260262 2019
112
Binocular non-stereoscopic cues can deceive clinical tests of stereopsis. 38
30962466 2019
113
Mirror image hypermetropic anisometropia in a pair of monozygotic twins. 38
30458238 2019
114
The Danish Rural Eye Study: prevalence of strabismus among 3785 Danish adults - a population-based cross-sectional study. 38
31025814 2019
115
[Do children with strabismus receive ophthalmic treatment? : Results from the KiGGS (German Health Interview and Examination Survey for Children and Adolescents) baseline survey (2003-2006)]. 38
30980175 2019
116
Referral to community care from school-based eye care programs in the United States. 38
30978336 2019
117
[Amblyopia-Basic principles and current diagnostic and therapeutic standards]. 38
30888470 2019
118
Clinical Profile of Low Vision Patients Attending in Low Vision Clinic in a Tertiary Care Hospital. 38
31086157 2019
119
[Ocular Phenotype and Complications in Patients with Tuberous Sclerosis Complex (TSC)]. 38
30763959 2019
120
Types of materials for frontalis sling surgery for congenital ptosis. 38
31013353 2019
121
Compared performance of Spot and SW800 photoscreeners on Chinese children. 38
29986946 2019
122
"PI-less DMEK": results of Descemet's membrane endothelial keratoplasty (DMEK) without a peripheral iridotomy. 38
30518974 2019
123
Vision Screening in Children in the Canton of St. Gallen. 38
30646426 2019
124
Factors influencing myopic shift in children after intraocular lens implantation. 38
31025587 2019
125
Evaluation of vision screening in five- to eight-year-old children living in Region Västra Götaland, Sweden - a prospective multicentre study. 38
30280519 2019
126
Adherence syndrome following inferior oblique anteropositioning - a case report. 38
30570375 2019
127
Evaluation of nutritional status in children with amblyopia. 38
30726406 2019
128
Attention deficits in Amblyopia. 38
31030000 2019
129
Late Ophthalmologic Referral of Anisometropic Amblyopia: A Retrospective Study of Different Amblyopia Subtypes. 38
30946787 2019
130
Use of log-scaled crowded visual acuity charts in clinical studies regarding amblyopia. 38
30675642 2019
131
Altered cortical morphology of visual cortex in adults with monocular amblyopia. 38
30854758 2019
132
Contrast and spatial frequency modulation for diagnosis of amblyopia: An electrophysiological approach. 38
30899850 2019
133
Impaired Spatial Hearing in Amblyopia: Evidence for Calibration of Auditory Maps by Retinocollicular Input in Humans. 38
30849170 2019
134
Portable System for Neuro-Optical Diagnostics Using Virtual Reality Display. 38
30901414 2019
135
Children with congenital and childhood cataract require frequent follow-up visits and examinations in general anaesthesia: considerations for the strain on families. 38
30860655 2019
136
Different trajectories in the development of visual acuity with different levels of crowding: The Milan Eye Chart (MEC). 38
30639454 2019
137
Retinal Microvasculature in Amblyopic Children and the Quantitative Relationship Between Retinal Perfusion and Thickness. 38
30913291 2019
138
Retinal oximetry in normal and amblyopic children: a pilot study. 38
30843376 2019
139
Objective vision screening using PlusoptiX for children aged 3-11 years in rural Turkey. 38
30871506 2019
140
Correction to: development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures. 38
30857536 2019
141
Case Series: Pediatric Herpes Simplex Keratitis. 38
30801497 2019
142
Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study. 38
30663207 2019
143
Amblyopia Risk Factors in Premature Children in the First 3 Years of Life. 38
30889262 2019
144
[Congenital abnormalities of the optic disc]. 38
30935696 2019
145
Reading ability of children treated for amblyopia. 38
30633876 2019
146
Acquired Pediatric Brown Syndrome Secondary to Sinusitis. 38
30907972 2019
147
Patient-oriented mobile applications in ophthalmology. 38
30168194 2019
148
A Randomized Trial of Binocular Dig Rush Game Treatment for Amblyopia in Children Aged 7 to 12 Years. 38
30352226 2019
149
A new counterintuitive training for adult amblyopia. 38
30847360 2019
150
Aniseikonia and anisometropia: implications for suppression and amblyopia. 38
30791133 2019
151
Driver licensing and motor vehicle crash rates among young adults with amblyopia and unilateral vision impairment. 38
30769086 2019
152
Evaluation of choroidal thickness in amblyopia using optical coherence tomography. 38
30808182 2019
153
Childhood Self-perceptions in Children With Amblyopia: Is the Problem the Disease or the Treatment? 38
30452493 2019
154
Refractive adaptation and efficacy of occlusion therapy in untreated amblyopic patients aged 12 to 40 years. 38
30397791 2019
155
Validation of dynamic random dot stereotests in pediatric vision screening. 38
30284041 2019
156
Development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures. 38
30736755 2019
157
[CHILDHOOD GLAUCOMA]. 38
30779490 2019
158
Neuregulin directed molecular mechanisms of visual cortical plasticity. 38
29464684 2019
159
Intranasal BDNF administration promotes visual function recovery in adult amblyopic rats. 38
29428822 2019
160
Prevalence of amblyopia and strabismus in Hani school children in rural southwest China: a cross-sectional study. 38
30782934 2019
161
Self-perception of School-aged Children With Amblyopia and Its Association With Reading Speed and Motor Skills. 38
30452518 2019
162
Visual prognosis of posterior and combined persistent fetal vasculature. 38
30712383 2019
163
Causes of visual impairment in applications for blindness certificates in a tertiary center of Bihar and its role in health planning. 38
30672470 2019
164
Visual acuity and amblyopia prevalence in 11- to 12-year-old Danish children from the Copenhagen Child Cohort 2000. 38
30280496 2019
165
Visual function in children with primary brain tumors. 38
30516642 2019
166
Prevalence of amblyopia in congenital blepharoptosis: a systematic review and Meta-analysis. 38
31341812 2019
167
The Use of β-Blockers for the Treatment of Periocular Hemangiomas in Infants: A Report by the American Academy of Ophthalmology. 38
30075202 2019
168
Duane Retraction Syndrome: Clinical Features and a Case Group-Specific Surgical Approach. 38
30516080 2019
169
Abnormal Outer Choroidal Vasculature in Amblyopia. 38
30733871 2019
170
Visuomotor Behaviour in Amblyopia: Deficits and Compensatory Adaptations. 38
31281344 2019
171
Fixation instability in amblyopia: Oculomotor disease biomarkers predictive of treatment effectiveness. 38
31325983 2019
172
Integration of past and current visual information during eye movements in amblyopia. 38
31239145 2019
173
Analysis of Peripapillary Choroidal Thickness in Unilateral Amblyopia. 38
30820286 2019
174
Altered Spontaneous Brain Activity of Children with Unilateral Amblyopia: A Resting State fMRI Study. 38
31428144 2019
175
Abnormal intra-network architecture in extra-striate cortices in amblyopia: a resting state fMRI study. 38
31334295 2019
176
[An Autopsy Case of Death After Deep Sedation of Thiopental]. 38
31292367 2019
177
Phenomenological approach to childhood cataract treatment in New Zealand using semi-structured interviews: how might we improve provision of care. 38
30782745 2019
178
Contrast sensitivity of amblyopic eyes in children with myopic anisometropia. 38
30054940 2019
179
Reduced amblyopic eye fixation stability cannot be simulated using retinal-defocus-induced reductions in visual acuity. 38
30389388 2019
180
The Effect of Combined Patching and Citalopram on Visual Acuity in Adults with Amblyopia: A Randomized, Crossover, Placebo-Controlled Trial. 38
31281343 2019
181
Ocular findings in posterior microphthalmos. 38
30930662 2019
182
Clinical Manifestations of Strabismus in Patients with Primary Congenital Glaucoma. 38
31348729 2019
183
Inverse Occlusion: A Binocularly Motivated Treatment for Amblyopia. 38
31015829 2019
184
Impact of co-occurring hearing and visual difficulties in childhood on educational outcomes: a longitudinal cohort study. 38
31206071 2019
185
Transient Dyschromatopsia, Static Form Agnosia, and Prosopagnosia Observed in a Patient with Anti-NMDA Receptor Encephalitis. 38
31061739 2019
186
Binocular Summation and Suppression of Contrast Sensitivity in Strabismus, Fusion and Amblyopia. 38
31354452 2019
187
Management Strategies of Ocular Abnormalities in Patients with Marfan Syndrome: Current Perspective. 38
30820290 2019
188
Amblyopia risk factors in congenital nasolacrimal duct obstruction: A longitudinal case-control study. 38
31194774 2019
189
Imaging Amblyopia: Insights from Optical Coherence Tomography (OCT). 38
31158044 2019
190
Periocular Asymmetry in Infants with Deformational Posterior Plagiocephaly. 38
30811279 2019
191
Clinical and surgical risk factors for consecutive exotropia. 38
29667435 2019
192
Visual Impairment and Eye Disease Among Children of Migrant Farmworkers. 38
30371918 2019
193
Efficacy of Smartphone-based Exercises in Conjunction with Modified Glasses Prescription in the Treatment of Convergence Insufficiency and Fusion Weakness. 38
30821632 2019
194
Diagnosis and Management Practice Patterns among Pediatric Ophthalmology Personnel in Israel. 38
30896300 2019
195
'It's too late'. Is it really? Considerations for amblyopia treatment in older children. 38
31259304 2019
196
Is LEA symbol better compared to Snellen chart for visual acuity assessment in preschool children? 38
31198896 2019
197
[Congenital glaucoma: Intraocular pressure and visual prognosis after trabeculectomy and functional rehabilitation for amblyopia]. 38
30598234 2019
198
Prevalence of amblyopia among preschool children in central south China. 38
31131243 2019
199
New Genotypes and Phenotypes in Patients with 3 Subtypes of Waardenburg Syndrome Identified by Diagnostic Next-Generation Sequencing. 38
30936914 2019
200
Axial length/corneal radius of curvature ratio and refractive development evaluation in 3- to 4-year-old children: the Shanghai Pudong Eye Study. 38
31236363 2019
201
Threshold Values of Myopic Anisometropia Causing Loss of Stereopsis. 38
31198605 2019
202
Pigmented contact lenses for managing ocular disorders. 38
30465853 2019
203
Analysis of Macular Vessel Density and Foveal Avascular Zone Using Spectral-Domain Optical Coherence Tomography Angiography in Children With Amblyopia. 38
30371915 2019
204
From suppression to stereoacuity: a composite binocular function score for clinical research. 38
30628744 2019
205
From Basic Visual Science to Neurodevelopmental Disorders: The Voyage of Environmental Enrichment-Like Stimulation. 38
31198418 2019
206
Prognosis after lamellar keratoplasty for limbal dermoids using preserved corneas. 38
30421318 2019
207
Visual outcomes of pediatric traumatic cataracts. 38
29609478 2019
208
Comparison of contrast sensitivity in macaque monkeys and humans. 38
31199217 2019
209
Early Predictors of Long-term Outcomes in Childhood Glaucoma. 38
30059407 2018
210
New advances in amblyopia therapy II: refractive therapies. 38
29871968 2018
211
Comparison of two methods for measuring contrast sensitivity in anisometropic amblyopia. 38
30555968 2018
212
ICL versus SMILE in management of anisometropic myopic amblyopia in children. 38
30502978 2018
213
Atropine Penalization Versus Occlusion Therapies for Unilateral Amblyopia after the Critical Period of Visual Development: A Systematic Review. 38
30328078 2018
214
Letter to editor: "is microtropia a reliable indicator for the presence of amblyopia in anisometropic patients?" by Lysons and Tapley. 38
30285526 2018
215
Cataract surgery in a patient with an angle gamma due to macular heterotopia. 38
30450443 2018
216
Indications, Clinical Outcomes, and Survival Rate of Pediatric Penetrating Keratoplasty in Suburban Malaysia: A 10-year Experience. 38
30800554 2018
217
The effects of the age of onset of strabismus on monocular and binocular visual function in genetically identical twins. 38
30502986 2018
218
Congenital Corneal Opacities Associated With Trisomy 8 Mosaicism Syndrome. 38
30272617 2018
219
Primary versus secondary intraocular lens implantation in traumatic cataract after open-globe injury in pediatric patients. 38
30297231 2018
220
Ophthalmic manifestations in patients with Leigh syndrome, French Canadian type. 38
30426811 2018
221
Decreased severity of age-related macular degeneration in amblyopic eyes. 38
29437581 2018
222
Spectacle Wear in Toddlers: Frequency of Wear and Impact of Treatment on the Child and Family. 38
30619663 2018
223
Progressive large pediatric corneal limbal dermoid management with tissue glue-assisted monolayer amniotic membrane transplantation: A case report. 38
30431578 2018
224
Temporal frequency discrimination in amblyopia. 38
30344704 2018
225
The effects of monocular training on binocular functions in anisometropic amblyopia. 38
28636883 2018
226
Dichoptic training in adults with amblyopia: Additional stereoacuity gains over monocular training. 38
28736224 2018
227
Orientation Tuning and Contrast Dependence of Continuous Flash Suppression in Amblyopia and Normal Vision. 38
30452600 2018
228
New advances in amblyopia therapy I: binocular therapies and pharmacologic augmentation. 38
29777043 2018
229
Binocular summation revisited: Beyond √2. 38
30102058 2018
230
Functional Visual Acuity. 38
30481803 2018
231
[Clinical and laboratory characteristics and genetic diagnosis of Kabuki syndrome]. 38
30392209 2018
232
Multiloculated Ciliary Body Cysts and Lenticular Coloboma: A Rare Phenotypic Variation Associated With Persistent Fetal Vasculature. 38
30388281 2018
233
[Unilateral combined strabismus surgery to correct esotropia : Video article on recession of the medial rectus muscle and plication of the lateral rectus muscle]. 38
30194471 2018
234
The Positive Predictive Value of Smartphone Photoscreening in Pediatric Practices. 38
30160295 2018
235
Factors related to amblyopia in congenital ptosis after frontalis sling surgery. 38
30463547 2018
236
Comparison of recurrent esotropia and consecutive exotropia with horizontal muscle reoperation in infantile esotropia. 38
30328559 2018
237
Prevalence of amblyopia in Bulgaria. 38
30325246 2018
238
[Modern High-Tech Contact Lenses 2018 - More than Correction of Refractive Error]. 38
30125906 2018
239
Evaluation of retinal structure in unilateral amblyopia using spectral domain optical coherence tomography. 38
30218712 2018
240
Evaluation of static and dynamic pupil characteristics in hyperopic anisometropic amblyopia. 38
30284453 2018
241
Smartphone Applications for Amblyopia Treatment: A Review of Current Apps and Professional Involvement. 38
29346038 2018
242
A pilot study using electronic reminders for amblyopia treatment. 38
30325237 2018
243
The key informant strategy to determine the prevalence and causes of functional low vision among children in South India. 38
29969337 2018
244
Special considerations for pediatric vitreoretinal surgery. 38
30637195 2018
245
Early Results of Penetrating Keratoplasty in Patients With Unilateral Chemical Injury After Simple Limbal Epithelial Transplantation. 38
29975208 2018
246
Increased choriocapillaris vessel density in amblyopic children: a case-control study. 38
30009947 2018
247
Prevalence of amblyopia and its impact on the academic performance of male medical students in Southern Saudi Arabia. 38
30581299 2018
248
Preschool Vision Screening: Where We Have Been and Where We Are Going. 38
30059651 2018
249
A Novel Dichoptic Optokinetic Nystagmus Paradigm to Quantify Interocular Suppression in Monocular Amblyopia. 38
30304459 2018
250
Juvenile Ocular Myasthenia Gravis: Presentation and Outcome of a Large Cohort. 38
30197221 2018
251
Long-Term Follow-up of Spasmus Nutans. 38
30332338 2018
252
Long-term motor and sensory outcomes after surgery for the nonaccommodative component of partially refractive accommodative esotropia. 38
30217512 2018
253
Decompression retinopathy following nonpenetrating deep sclerectomy for primary congenital glaucoma. 38
30185152 2018
254
Surgical intervention for paediatric blepharoptosis: a 6-year case series. 38
30244388 2018
255
Amblyopia: It is time to take action. 38
30127179 2018
256
The prevalence of amblyopia in Iran: A systematic review. 38
30197947 2018
257
Visual Search in Amblyopia: Abnormal Fixational Eye Movements and Suboptimal Sampling Strategies. 38
30208418 2018
258
Dichoptic Attentive Motion Tracking is Biased Toward the Nonamblyopic Eye in Strabismic Amblyopia. 38
30242356 2018
259
[Progress of Researches on Brain Mechanism Underlying Regulatory Effect of Acupuncture Intervention on Visual Plasticity of Amblyopia]. 38
30232871 2018
260
Atypical presentation of Best Disease. 38
29853419 2018
261
Sensitivity to Velocity- and Disparity-Based Cues to Motion-In-Depth With and Without Spared Stereopsis in Binocular Visual Impairment. 38
30193309 2018
262
Optical Coherence Tomography in Optic Nerve Hypoplasia: Correlation With Optic Disc Diameter, Nerve Fiber Layer Thickness, and Visual Function. 38
29252690 2018
263
Management of Herpes Simplex Virus Keratitis in the Pediatric Population. 38
29794647 2018
264
Comparison of the Effect of Cycloplegia on Astigmatism Measurements in a Pediatric Amblyopic Population: A Prospective Study. 38
29913022 2018
265
Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study. 38
30046935 2018
266
Effectiveness of binocularity-stimulating treatment in children with residual amblyopia following occlusion. 38
30236086 2018
267
Current management of childhood ptosis. 38
30096088 2018
268
Is microtropia a reliable indicator of the presence of amblyopia in anisometropic patients? 38
30060696 2018
269
Well-Child Visits for Infants and Young Children. 38
30215922 2018
270
Macular Thickness in Moderate to Severe Amblyopia. 38
30091310 2018
271
OCT angiography findings in children with amblyopia. 38
30031875 2018
272
[Amblyopia and refractive error]. 38
30096724 2018
273
Fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. 38
30150750 2018
274
Assessing amblyopia treatment using multifocal visual evoked potentials. 38
30103718 2018
275
Effect of amblyopia treatment on choroidal thickness in hypermetropic anisometropic amblyopia using swept-source optical coherence tomography. 38
30170555 2018
276
Primary Care Implementation of Instrument-Based Vision Screening for Young Children. 38
29090597 2018
277